A Prospective, Post-marketing, Non-interventional Study of RISankizumab Evaluating Real-world Clinical Effectiveness in Crohn's Disease (APPRISE)
A Prospective, Post-marketing, Non-interventional Study of RISankizumab Evaluating Real-world Clinical Effectiveness in Crohn's Disease (APPRISE)
Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. This study will assess how safe and effective risankizumab is in treating moderately to severely active CD in real world. Adverse events and change in disease activity will be assessed.
Risankizumab is a drug approved for the treatment of CD. All study participants will receive risankizumab as prescribed by their study doctor in accordance with approved local label. Approximately 1000 participants will be enrolled worldwide.
Participants will receive risankizumab as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 36 months.
There is expected to be no additional burden for participants in this trial. Study visits may be conducted on-site or virtually as per standard of care.
Inclusion Criteria:
Exclusion Criteria:
Vienna, State of Vienna 1060, Austria
Edmonton, Alberta T5R 1W2, Canada
Hamilton, Ontario L8S 4K1, Canada
North York, Ontario M2K 2W2, Canada
North York, Ontario M6A 3B4, Canada
Montreal, Quebec H1T 2M4, Canada
Montreal, Quebec H4A 3J1, Canada
St-Priest-en-Jarez, Pays de la Loire Region 42270, France
Epagny Metz Tessy, 74370, France
Neuilly-sur-Seine, Île-de-France Region 92200, France
Kassel, Hesse 34117, Germany
Minden, North Rhine-Westphalia 32423, Germany
Berlin, 12559, Germany
Berlin-Zehlendorf, 14163, Germany
Hirosaki-shi, Aomori 036-8203, Japan
Sakura-shi, Chiba 285-8741, Japan
Asahikawa-shi, Hokkaido 078-8510, Japan
Nishinomiya-shi, Hyōgo 663-8501, Japan
Shiwa-gun, Iwate 028-3695, Japan
Kyoto, Kyoto 602-8566, Japan
Hirakata-shi, Osaka 573-1191, Japan
Shimotsuke-shi, Tochigi 329-0498, Japan
Bunkyo-ku, Tokyo 113-8519, Japan
Minato-ku, Tokyo 105-8471, Japan
Minato-ku, Tokyo 108-8642, Japan
Mitaka-shi, Tokyo 181-8611, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Shinjuku-ku, Tokyo 162-8666, Japan
Santiago de Compostela, A Coruna 15706, Spain